Loading
A phase 1 trial of TG6050 run by Transgene, terminated.
A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) is a phase 1 interventional study registered as NCT05788926 by Transgene, with 22 participants enrolled, started 2023-04-05. Conditions recorded: Non-small Cell Lung Cancer. Interventions recorded: TG6050.
Shares Transgene and the tag pipeline.
Shares Transgene and the tag pipeline.
Shares Transgene and the tag pipeline.
Shares Transgene, Non-small-cell lung cancer and the tag pipeline.
Shares Transgene, Non-small-cell lung cancer and the tag pipeline.
Shares Transgene and the tag pipeline.
Shares Non-small-cell lung cancer and the tag pipeline.
Shares Non-small-cell lung cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/